Chris Buntrock, MD
Ophthalmology · Farmington, NMNPI 1073531851
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 41.4% of the total. Reporting peaked in 2019 at $142 and has fallen 66.2% since, to $48 in 2024. That places this record below the midpoint for ophthalmology clinicians in NM, where the typical reported total is $868.
Across 13 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114
- Bausch & Lomb, A Division Of Bausch Health US, LLC$45
- Alcon$34
- Apellis Pharmaceuticals, Inc.$20
- Ocular Therapeutix, Inc.$20
- Glaukos Corporation$16
- plus $25 from 2 others
What the payments were for
- Food & beverage$275100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $114 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $45 |
| Alcon | 2 | $34 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Ocular Therapeutix, Inc. | 1 | $20 |
| Glaukos Corporation | 1 | $16 |
| Bausch & Lomb Americas Inc. | 1 | $13 |
| Novartis | 1 | $12 |
How this compares
$275 in reported general payments places this provider in the 30th percentile of 81 ophthalmology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 291 | $12,494 |
| Ofloxacin | 110 | $1,228 |
| Ciprofloxacin Hcl | 94 | $1,120 |
| Fluorometholone | 14 | $966 |
| Ketorolac Tromethamine | 29 | $669 |
| MoxifloxacinMoxifloxacin Hcl | 17 | $638 |
| Latanoprost | 52 | $633 |
| Brimonidine Tartrate | 16 | $623 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 41 | $611 |
| Dorzolamide Hcl | 21 | $422 |
| Atropine Sulfate | 15 | $403 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 18 | $344 |
| Timolol Maleate | 28 | $245 |
| ErythromycinErythromycin Base | 13 | $187 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Farmington
- Scott AllenFarmington$868
- Mark GallardoLas Cruces$1.2M
- Robert MelendezAlbuquerque$349K
- John PitcherAlbuquerque$307K
- Christopher RoybalAlbuquerque$51K
- Paul GulbasRuidoso$14K
- Stephen ColemanAlbuquerque$12K
- Rachel DavisAlbuquerque$10K
- Ian ThompsonAlbuquerque$10K
- Paul SanchezAlbuquerque$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.